Product Images Sacubitril And Valsartan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Sacubitril And Valsartan NDC 71610-940 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label - 71610 0940 89

This text provides information about a medication named Sacubitril/Valsartan, along with a number sequence and alphanumeric characters. The text also mentions "BATCH 1" which could be associated with a specific batch or production code. This text seems to be a combination of product name, codes, and possibly dosage instructions.*
figure-1 - sacubitril valsartan figure 1

This is a list of coadministered drugs with geometric mean ratio and 90% confidence interval for each drug in relation to the reference drug. The drugs listed include furosemide, warfarin, digoxin, carvedilol, levonorgestrel, ethinyl estradiol, amlodipine, metformin, atorvastatin, and sildenafil. The text suggests a comparison of these drugs in terms of their effects when coadministered.*
sacubitril-valsartan-figure-3.jpg - sacubitril valsartan figure 3

The text describes a study named PARADIGM-HF that evaluates the time to first occurrence of cardiovascular death (CV) or heart failure hospitalizations. The study compares the outcomes of patients treated with Sacubitril and Valsartan against those treated with Enalapril. The text includes statistical information, hazard ratios, confidence intervals, and the number of patients at risk over time since randomization in days. It also mentions the cumulative failure rate of heart failure hospitalizations in the study. The study results indicate a significant difference in outcomes between the two treatment groups.*
sacubitril-valsartanl-figure-4.jpg - sacubitril valsartanl figure 4

The text provides data on various subgroups related to population distribution, including age, gender, weight, race, region, NYHA Class, estimated GFR, diabetes, blood pressure, ejection fraction, atrial fibrillation, NT-proBNP, hypertension, prior medication use, hospitalization history, time since diagnosis, cause of heart failure, and the usage of medications like Sacubitril and Valsartan and Enalapril. It also includes corresponding numbers and percentages in different categories for further analysis. This information is useful for analyzing and understanding different factors related to heart failure and related treatments.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.